Tumor-derived extracellular vesicles convey solute transporters to induce bioenergetic dependence shift contributing to treatment resistance
Theranostics · 2024
DOI: 10.7150/thno.100374 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2024. Verfasst von Jayshree Hirpara und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Science Institute of Singapore, National University of Singapore, Singapore. Hauptthemen laut MEDLINE: Extracellular Vesicles, Drug Resistance, Neoplasm, Tumor Microenvironment. Die Arbeit wurde bisher 13-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Rationale
Growing evidence points to the tumor microenvironment's role in developing drug resistance. A key element of this microenvironment is inter-cellular communication, which includes the release of membrane-encapsulated vesicles containing various cargo, known as extracellular vesicles (EVs). Understanding how EVs contribute to acquired resistance holds significant clinical implications.
Methods
Differential centrifugation-based methods were used to isolate EVs from established cell lines and human plasma. TMT labeling proteomics analysis of EVs revealed an abundance of metabolic transporter proteins. Increased expression of SLC1A5 in EVs of patient-derived plasma and cell lines rendered resistant to tyrosine kinase inhibitors and its relationship with progression-free survival was assessed using Kaplan-Meier survival plot. Gene knockdown and overexpression of SLC1A5 were used to validate its effect on Tyrosine kinase inhibitor (TKI) resistance. Co-culture assays using inserts was used to evaluate the effect of resistant EVs on normal fibroblasts and epithelial cells. Next, mouse-derived tumor slices (MDTS) were cultured in vitro to assess the effect of resistant EVs.
Results
We report here that TKI-sensitive cells are rendered resistant upon incubation with EVs derived from TKI-resistant cell lines. Metabolic transporters, in particular SLC1A5 and SLC25A5, are upregulated in EVs derived from TKI-resistant cells and plasma from patients harbouring TKI-resistant tumors and in TKI-resistant cell lines. Furthermore, we also provide evidence for the increased abundance of pSTAT3 and the stemness marker ALDH1A1 upon EV-induced resistance. Notably, resistant EVs trigger phenotypic and functional switching of lung-derived fibroblasts into tumor-associated fibroblasts, significantly increasing their migratory and invasive capacities.
Conclusions
Our findings support the role of metabolic transporters within tumor-derived EVs in reshaping the tumor microenvironment to promote therapy resistance, which could have potential diagnostic, prognostic, and therapeutic implications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Science Institute of Singapore, National University of Singapore, Singapore.
- Departmental of Biomedical Engineering, National University of Singapore, Singapore.
- Department of Pharmacology, National University of Singapore, Singapore.
- NUS Center for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
- Department of Haematology-Oncology, National University Hospital, Singapore.
- The N. 1 Institute of Health, National University of Singapore.
Zitieren
APA
Hirpara, J., Thuya, W. L., Cheow, S. H., Fernando, K., Eu, J. Q., Wang, L., Wong, A. L., Fong, E. L. S., Ali, A. B., Ding, L. W., Zhuoran, W., Lim, Y. C., Pervaiz, S., & Goh, B. C. (2024). Tumor-derived extracellular vesicles convey solute transporters to induce bioenergetic dependence shift contributing to treatment resistance. Theranostics. https://doi.org/10.7150/thno.100374
Vancouver
Hirpara J, Thuya WL, Cheow SH, Fernando K, Eu JQ, Wang L, et al. Tumor-derived extracellular vesicles convey solute transporters to induce bioenergetic dependence shift contributing to treatment resistance. Theranostics. 2024. doi:10.7150/thno.100374
BibTeX
@article{Hirpara2024,
author = {Hirpara, Jayshree and Thuya, Win Lwin and Cheow, Sok-Hwee and Fernando, Kanishka and Eu, Jie Qing and Wang, Lingzhi and Wong, Andrea Li-Ann and Fong, Eliza Li Shan and Ali, Azhar Bin and Ding, Ling-Wen and Zhuoran, Wu and Lim, Yaw-Chyn and Pervaiz, Shazib and Goh, Boon-Cher},
title = {Tumor-derived extracellular vesicles convey solute transporters to induce bioenergetic dependence shift contributing to treatment resistance},
journal = {Theranostics},
year = {2024},
doi = {10.7150/thno.100374}
}
EUVIMED